![Jean-Marc Janodet](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jean-Marc Janodet
Plus aucun poste en cours
Profil
Jean-Marc Janodet held director positions at Wendel SE and Stallergenes SA.
Anciens postes connus de Jean-Marc Janodet
Sociétés | Poste | Fin |
---|---|---|
STALLERGENES | Directeur/Membre du Conseil | - |
WENDEL | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Sociétés liées
Sociétés cotées | 1 |
---|---|
WENDEL | Finance |
Entreprise privées | 1 |
---|---|
Stallergenes SA
![]() Stallergenes SA Pharmaceuticals: MajorHealth Technology Stallergenes SA is an international biopharmaceutical company, which engages in the manufacture and sale of pharmaceutical products for the treatment of allergy-related respiratory diseases. The company operates through the Allergen Immunotherapy segment, which provides products and services for the desensitization of allergy-related respiratory conditions. Its products include a range of sublingual route and subcutaneous route products for the treatment of respiratory diseases such as rhino-conjunctivitis, rhinitis, and allergic asthma. Stallergenes was founded in 1962 and is headquartered in Antony, France. | Health Technology |